WHO ICTRP trial

A randomized controlled study of the Prevail Drug-Coated Balloon in subjects…

JPRN-jRCT2032240716 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCT2032240716
Public title A randomized controlled study of the Prevail Drug-Coated Balloon in subjects with in-stent restenosis and a single arm prospectively enrolled study of the Prevail Drug-Coated Balloon for de novo lesions in small vessel disease
Scientific title A randomized controlled study of the Prevail Drug-Coated Balloon in subjects with in-stent restenosis and a single arm prospectively enrolled study of the Prevail Drug-Coated Balloon for de novo lesions in small vessel disease - Prevail Global
Primary sponsor Hamajima Takashi
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase 3
Countries United States;Japan;France;Japan;Germany;Japan;Ireland;Japan;United Kingdom;Japan;Hong Kong;Japan;Korea;Japan;Singapore;Japan
Conditions In-stent restenosis (ISR) and de novo lesions in small vessel diseas
Interventions PCI using DCB (ISR:MDT-0124 DCB/Agent DCB, DNSV: MDT-0124 DCB)
Registration date May 3, 2025
Target size 97
Secondary IDs NCT06535854
Registry page jrct.mhlw.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations